Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
The report details the trend, potential and market size of Immuno-oncology Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immuno-oncology Therapymarket, defines the market attractiveness level of Immuno-oncology Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immuno-oncology Therapy industry, describes the types of Immuno-oncology Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immuno-oncology Therapy market and the development prospects and opportunities of Immuno-oncology Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immuno-oncology Therapy market in Chapter 13.
By Player:
Eli-Lilly
AstraZeneca
Pfizer
Spectrum Pharmaceuticals
Janssen Biotech
Roche
Sanofi
Amgen
Takeda
Bristol-Myers Squibb
Novartis
GlaxoSmithKline
Merck
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
By End-User:
Hospitals
Ambulatory Surgical Center
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immuno-oncology Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immuno-oncology Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immuno-oncology Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immuno-oncology Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immuno-oncology Therapy Market Analysis and Outlook to 2022
-
7.1 Global Immuno-oncology Therapy Consumption (2017-2022)
-
7.2 United States Immuno-oncology Therapy Consumption (2017-2022)
-
7.3 Europe Immuno-oncology Therapy Consumption (2017-2022)
-
7.4 China Immuno-oncology Therapy Consumption (2017-2022)
-
7.5 Japan Immuno-oncology Therapy Consumption (2017-2022)
-
7.6 India Immuno-oncology Therapy Consumption (2017-2022)
-
7.7 South Korea Immuno-oncology Therapy Consumption (2017-2022)
8 Region and Country-wise Immuno-oncology Therapy Market Analysis and Outlook to 2028
-
8.1 Global Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.2 United States Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.4 China Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.6 India Immuno-oncology Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Immuno-oncology Therapy Consumption Forecast (2022-2028)
9 Global Immuno-oncology Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Immuno-oncology Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Immuno-oncology Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Immuno-oncology Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Immuno-oncology Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immuno-oncology Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Immuno-oncology Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immuno-oncology Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immuno-oncology Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immuno-oncology Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immuno-oncology Therapy Market Competitive Analysis
-
14.1 Eli-Lilly
-
14.1.1 Eli-Lilly Company Details
-
14.1.2 Eli-Lilly Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli-Lilly Immuno-oncology Therapy Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Immuno-oncology Therapy Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Immuno-oncology Therapy Product and Service
-
14.4 Spectrum Pharmaceuticals
-
14.4.1 Spectrum Pharmaceuticals Company Details
-
14.4.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Service
-
14.5 Janssen Biotech
-
14.5.1 Janssen Biotech Company Details
-
14.5.2 Janssen Biotech Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Janssen Biotech Immuno-oncology Therapy Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Immuno-oncology Therapy Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Immuno-oncology Therapy Product and Service
-
14.8 Amgen
-
14.8.1 Amgen Company Details
-
14.8.2 Amgen Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgen Immuno-oncology Therapy Product and Service
-
14.9 Takeda
-
14.9.1 Takeda Company Details
-
14.9.2 Takeda Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Immuno-oncology Therapy Product and Service
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Details
-
14.10.2 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Immuno-oncology Therapy Product and Service
-
14.12 GlaxoSmithKline
-
14.12.1 GlaxoSmithKline Company Details
-
14.12.2 GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 GlaxoSmithKline Immuno-oncology Therapy Product and Service
-
14.13 Merck
-
14.13.1 Merck Company Details
-
14.13.2 Merck Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Merck Immuno-oncology Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immuno-oncology Therapy
-
Figure Immuno-oncology Therapy Picture
-
Table Global Immuno-oncology Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immuno-oncology Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immuno-oncology Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immuno-oncology Therapy Consumption by Country (2017-2022)
-
Figure United States Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immuno-oncology Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immuno-oncology Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immuno-oncology Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immune System Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Center Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune System Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immuno-oncology Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immuno-oncology Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli-Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli-Lilly Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli-Lilly Immuno-oncology Therapy Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immuno-oncology Therapy Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Immuno-oncology Therapy Product and Service
-
Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Immuno-oncology Therapy Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Immuno-oncology Therapy Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Immuno-oncology Therapy Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Immuno-oncology Therapy Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Immuno-oncology Therapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Immuno-oncology Therapy Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Immuno-oncology Therapy Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Immuno-oncology Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Immuno-oncology Therapy Product and Service
-
